Communication between ephrinB2 and ephb4 within the osteoblast lineage

Advances in Experimental Medicine and Biology

Volumn 658, Issue , 2010, Pages 51-60

  Martin, T J ^a   Allan, E H ^b   Ho, P W M ^b   Gooi, J H ^b   Quinn, J M W ^b   Gillespie, M T ^b   Krasnoperov, V ^b   Sims, N A ^b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b NONE

Author keywords

Bone remodeling; Ephrins; Osteoblast; PTHrP

Indexed keywords

EPHRIN B2; EPHRIN B4; EPHRIN RECEPTOR B2; EPHRIN RECEPTOR B4; MEMBRANE PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROTEIN C FOS; SOMATOMEDIN B; SOMATOMEDIN C; TRANSCRIPTION FACTOR NFAT; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR DECOY RECEPTOR; UNCLASSIFIED DRUG;

BONE MATRIX; BONE REMODELING; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL LINEAGE; CONFERENCE PAPER; MINERALIZATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOCYTE; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

ANIMALS; CELL COMMUNICATION; CELL LINEAGE; EPHRIN-B2; HUMANS; MICE; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; RATS; RECEPTOR, EPHB4; SIGNAL TRANSDUCTION;

EID: 77954660656     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1050-9_6     Document Type: Conference Paper

References (30)

1. Allan E.H. Hausler K.D. Wei T. Gooi J.H. Quinn J.M. Crimeen-Irwin B. Pompolo S. Sims N.A. Gillespie M.T Onyia J.E. & Martin T.J. 2008 EphrinB2 Regulation by Parathyroid Hormone (PTH) and PTHrP Revealed by Molecular Profiling in Differentiating Osteoblasts. J Bone Miner Res 23(8) 1170-1181. (Pubitemid 352040173)
2. Bonewald L.F. 2007 Osteocyte messages from a bony tomb. Cell Metab 5(6) 410-411. (Pubitemid 46825500)
3. Centrella M. McCarthy T.L. & Canalis E. 1991 Transforming growth factor-beta and remodeling of bone. J Bone Joint Surg Am 73(9) 1418-1428.
4. Civitelli R. 2008 Cell-cell communication in the osteoblast/osteocyte lineage. Arch Biochem Biophys 473(2) 188-192.
5. Compagni A. Logan M. Klein R. & Adams R.H. 2003 Control of skeletal patterning by ephrinB1-EphB interactions. Dev Cell 5(2) 217-230. (Pubitemid 37006467)
6. Everts V. Delaisse J.M. Korper W. Jansen D.C. Tigchelaar-Gutter W. Saftig P. & Beertsen W. 2002 The bone lining cell: its role in cleaning Howship's lacunae and initiating bone formation. J Bone Miner Res 17(1) 77-90. (Pubitemid 33150999)
7. Gray C. Boyde A. & Jones S.J. 1996 Topographically induced bone formation in vitro: implications for bone implants and bone grafts. Bone 18(2) 115-123. (Pubitemid 26092591)
8. Hamada K. Oike Y. Ito Y. Maekawa H. Miyata K. Shimomura T. & Suda T. 2003 Distinct roles of ephrin-B2 forward and EphB4 reverse signaling in endothelial cells. Arterioscler Thromb Vasc Biol 23(2) 190-197. (Pubitemid 36231927)
9. Himanen J.P. Chumley M.J. Lackmann M. Li C. Barton W.A. Jeffrey P.D. Vearing C. Geleick D. Feldheim D.A. Boyd A.W. Henkemeyer M. & Nikolov D.B. 2004 Repelling class discrimination: ephrin-A5 binds to and activates EphB2 receptor signaling. Nat Neurosci 75501-509. (Pubitemid 38544589)
10. Himanen J.P. & Nikolov D.B. 2003 Eph receptors and ephrins. Int J Biochem Cell Biol 35(2) 130-134. (Pubitemid 35441270)
11. Holmberg J. Armulik A. Senti K.A. Edoff K. Spalding K. Momma S. Cassidy R. Flanagan J.G. & Frisen J. 2005 Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev 19(4) 462-471. (Pubitemid 40256278)
12. Kertesz N. Krasnoperov V. Reddy R. Leshanski L. Kumar S.R. Zozulya S. & Gill P.S. 2006 The soluble extracellular domain of EphB4 (sEphB4) antagonizes EphB4-EphrinB2 interaction modulates angiogenesis and inhibits tumor growth. Blood 107(6) 2330-2338. (Pubitemid 43345552)
13. Koolpe M. Burgess R. Dail M. & Pasquale E.B. 2005 EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity. J Biol Chem 280(17) 17301-17311. (Pubitemid 41389199)
14. Lips P. Courpron P. & Meunier P.J. 1978 Mean wall thickness of trabecular bone packets in the human iliac crest: changes with age. Calcif Tissue Res 26(1) 13-17. (Pubitemid 9088823)
15. Lu Q Sun E.E. Klein R.S. Flanagan J.G. 2001 Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction. Cell 105(1) 69-79. (Pubitemid 32323917)
16. Miao D. He B. Jiang Y. Kobayashi T. Soroceanu M.A. Zhao J. Su H. Tong X. Amizuka N. Gupta A. Genant H.K. Kronenberg H.M. Goltzman D. & Karaplis A.C. 2005 Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34. J Clin Invest 115(9) 2402-2411. (Pubitemid 41266202)
17. Mohan S. & Baylink D.J. 1991 Bone growth factors. Clin Orthop Relat Res 263 30-48.
18. Murai K.K. & Pasquale E.B. 2003 'Eph'ective signaling: forward reverse and crosstalk. J Cell Sci 116Pt (14) 2823-2832. (Pubitemid 36926971)
19. Nakamura M. Udagawa N. Matsuura S. Mogi M. Nakamura H. Horiuchi H. Saito N. Hiraoka B.Y. Kobayashi Y. Takaoka K. Ozawa H. Miyazawa H. & Takahashi N. 2003 Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144(12) 5441-5449. (Pubitemid 37476073)
20. Noble B.S. Peet N. Stevens H.Y. Brabbs A. Mosley J.R. Reilly G.C. Reeve J. Skerry T.M. & Lanyon L.E. 2003 Mechanical loading: biphasic osteocyte survival and targeting of osteoclasts for bone destruction in rat cortical bone. Am J Physiol Cell Physiol 28(44) C934-C943. (Pubitemid 36336949)
21. Oreffo R.O. Mundy G.R. Seyedin S.M. & Bonewald L.F. 1989 Activation of the bonederived latent TGF beta complex by isolated osteoclasts. Biochem Biophys Res Commun 158(3) 817-823. (Pubitemid 19075997)
22. Parfitt A.M. 1996 Skeletal heterogeneity and the purposes of bone remodeling: implications for the understanding of osteoporosis. In: Marcus R Feldman D Kelsey J (eds.) Osteoporosis. Academic Press San Diego CA pp. 315-339.
23. Parfitt A.M. 2002 Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression. Bone 30(1) 5-7. (Pubitemid 34044294)
24. Pasquale E.B. 2005 Eph receptor signaling [stet] casts a wide net on cell behaviour. Nat Rev Mol Cell Biol 66 462-475. (Pubitemid 40780558)
25. Robling A.G. Bellido T. & Turner C.H. 2006 Mechanical stimulation in vivo reduces osteocyte expression of sclerostin. J Musculoskelet Neuronal Interact 6(4) 354. (Pubitemid 46099713)
26. Sims N.A. Jenkins B.J. Quinn J.M. Nakamura A. Glatt M. Gillespie M.T. Ernst M. & Martin T.J. 2004 Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113(3) 379-389. (Pubitemid 38544182)
27. Suda T. Takahashi N. Udagawa N. Jimi E. Gillespie M.T. & Martin T.J. 1999 Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20(3) 345-357. (Pubitemid 30649812)
28. van Bezooijen R.L. ten Dijke P. Papapoulos S.E. & Lowik C.W. 2005 SOST/sclerostin an osteocyte-derived negative regulator of bone formation. Cytokine Growth Factor Rev 16(3) 319-327. (Pubitemid 40910321)
29. Yancopoulos G.D. Davis S. Gale N.W. Rudge J.S. Wiegand S.J. & Holash J. 2000 Vascular-specific growth factors and blood vessel formation. Nature 407(6801) 242-248.
30. Zhao C. Irie N. Takada Y. Shimoda K. Miyamoto T. Nishiwaki T. Suda T. & Matsuo K. 2006 Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab 4(2) 111-121. (Pubitemid 44138718)